Compositions for adjuvant therapy of lung cancer, their preparation methods and applications

By preparing a composition containing traditional Chinese medicines such as mulberry, the problem of recurrence and metastasis in the treatment of lung cancer has been solved, and effective inhibition of lung cancer cells has been achieved, providing a safe adjuvant treatment option.

CN117482182BActive Publication Date: 2026-06-30BEIJING CAPITALBIO PHARMA CO LTD

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
BEIJING CAPITALBIO PHARMA CO LTD
Filing Date
2023-11-01
Publication Date
2026-06-30

AI Technical Summary

Technical Problem

Current treatments for lung cancer lack effective strategies for preventing recurrence and metastasis, and modern medical treatments can damage normal cells. Traditional Chinese medicine, with its synergistic effects across multiple pathways and targets, can be helpful as an adjunct therapy for lung cancer.

Method used

A traditional Chinese medicine composition is provided, consisting of mulberry, amla, nutmeg, euryale seed, rose, bamboo leaf, chrysanthemum, water chestnut, cinnamon, citron, clove and papaya, which is prepared into freeze-dried powder by water extraction and freeze-drying, and is used to prepare drugs or food therapy products for adjuvant treatment of lung cancer, inhibiting the proliferation and migration of lung cancer cells.

Benefits of technology

This traditional Chinese medicine composition has significant cell-killing and migration-inhibiting effects on human lung cancer cells A549, which can slow down the progression of lung cancer, improve symptoms, and provide long-term intervention and treatment effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

This invention relates to the fields of traditional Chinese medicine and food technology, specifically to compositions, their preparation methods, and applications. The invention provides compositions, their preparation methods, and applications. The compositions provided by this invention have been experimentally verified to have a significant inhibitory effect on the proliferation and migration of human lung cancer cells A549 in vitro and in vivo. They can be used to prepare pharmaceutical preparations, dietary supplements, health products, etc., for adjuvant therapy / treatment of lung cancer. They can be used for relatively long-term intervention in lung cancer patients to slow disease progression and improve patient symptoms.
Need to check novelty before this filing date? Find Prior Art